Table 2.

Study outcomes assessed.

Primary outcome
Ischemic stroke volume on magnetic resonance imaging (MRI) performed at 3 months
Secondary outcomes
Hemorrhagic transformation (defined as type 2 parenchymal hemorrhage) Evolution of ischemic stroke volume from pre-treatment MRI to control MRI (48 h after intervention). Any stroke (ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrahge) Death of any cause Functional outcome at 3 months: mRS Impact of stroke throughout the first 3 months: Stroke Impact Scale Cognitive performance at 3 months: Montreal Cognitive Assessment scale (MoCA) Functional Independence at 3 months: Barthel Scale Upper limb Capacity at 3 months: Stroke Upper Limb Capacity Scale Mood at 3 months: Hospital Anxiety and Depression Scale Quality of life at 3 months: EuroQol Scale (EQ-5D) Gait speed at 3 months (10 m test) Temporo-spatial gait organization at 3 months (GAITRIte speed) Deglutition at 3 months: Functional Oral Intake Scale Language: Aphasia Rapid Test